Prana COO Diane Angus And Head Of Research Robert Cherny: An Interview With PharmAsia News (part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Execs talk about Aussie biotech’s unique mechanism of action in neurodegenerative drug development.
You may also be interested in...
Aussie Biotech Prana’s COO Diane Angus: An Interview With PharmAsia News (Part 1 of 2)
Prana’s lead compound, PB2 for Alzheimer’s, recently completed Phase IIa.
Asia Spotlight: Ascendancy Healthcare CEO Sandy Zweifach On The Gap In China
Seeing a gap between the large infrastructure being built in China by multinational and domestic companies, Ascendancy hopes to be an interface to help China access drugs from the West.
Ascendancy Healthcare CEO Sandy Zweifach On The Gap In China: An Interview With PharmAsia News (Part 2 of 2)
Seeing a gap between the large infrastructure being built in China by multinational and domestic companies, Ascendancy hopes to be an interface to help China access drugs from the West.